错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14)

  • Hongwei Tang,
  • Huihuang Yan,
  • Suganti Shivaram,
  • Stacey Lehman,
  • Neeraj Sharma,
  • James Smadbeck,
  • Cinthya Zepeda-Mendoza,
  • Shulan Tian,
  • Yan Asmann,
  • Celine Vachon,
  • Alexandre Gaspar Maia,
  • Jonathan Keats,
  • P. Leif Bergsagel,
  • Rafael Fonseca,
  • A. Keith Stewart,
  • Joel-Sean Hsu,
  • Richard K. Kandasamy,
  • Akhilesh Pandey,
  • Marcella A. Kaddoura,
  • Francesco Maura,
  • Amit Mitra,
  • S. Vincent Rajkumar,
  • Shaji K. Kumar,
  • Eran Elhaik,
  • Esteban Braggio,
  • Linda B. Baughn

摘要

Multiple myeloma (MM) is a plasma cell (PC) malignancy characterized by cytogenetic abnormalities, such as t(11;14)(q13;q32), resulting in CCND1 overexpression. The rs9344 G allele within CCND1 is the most significant susceptibility allele for t(11;14). Sequencing data from 2 independent cohorts, CoMMpass (n = 698) and Mayo Clinic (n = 661), confirm the positive association between the G allele and t(11;14). Among 80% of individuals heterozygous for rs9344 with t(11;14), the t(11;14) event occurs on the G allele, demonstrating a biological preference for the G allele in t(11;14). Within t(11;14), the G allele is associated with higher CCND1 expression and elevated H3K27ac and H3K4me3. CRISPR/Cas9 mediated A to G conversion resulted in increased H3K27ac over CCND1 and elevated CCND1 expression. ENCODE ChIP-seq data supported a PAX5 binding site within the enhancer region covering rs9344, showing preferential binding to the G allele. Overexpression of PAX5 resulted in increased CCND1 expression. These results support the importance of rs9344 G enhancer in increasing CCND1 expression in MM.